Rocket


Overview
Financials
News + Filings
Key Docs
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other



Sinorama Corp (TBD) Create: Alert

All | News | Filings
Date FiledTypeDescription
01/10/2019 GN Emerald Health Therapeutics Closes Emerald Health Naturals Joint Venture
12/10/2018 GN Emerald Health Sees License Expansion of Pure Sunfarms Cannabis Production Operation to 687,000 Square Feet, one of Largest Production Capacities in Canada
12/07/2018 GN Emerald Health Therapeutics Closes $10.8 Million Prospectus Sale
12/04/2018 GN Emerald Joint Venture Receives Licenses from Health Canada to Sell Proprietary Products Supporting the Endocannabinoid System
11/30/2018 GN Emerald Health Therapeutics Reports 3rd Quarter 2018 Financial Results and Provides Corporate Update
11/28/2018 GN Emerald Health Therapeutics Announces Executive Chairman Avtar Dhillon Appointed as President; CEO Chris Wagner Steps Down
11/22/2018 GN Emerald Health Therapeutics Appoints Agro-Biotech President
11/22/2018 GN Emerald Health Therapeutics nomme le président d'Agro-Biotech
11/07/2018 GN Emerald Health Therapeutics Fulfilling Supply Commitments with Provincial Adult-Use Cannabis Shipments
10/10/2018 GN Emerald Health Therapeutics' Subsidiary Northern Vine Receives International Government Approvals and Completes Import and Export of Cannabis Oils for Research & Development
10/09/2018 GN Emerald Health Therapeutics' Wholly Owned Subsidiary Northern Vine to Participate in Series of Cannabis Testing Seminars Hosted by Thermo Fisher Scientific
10/03/2018 GN Emerald Health Therapeutics Enters Research Agreement with VivaCell Biotechnologies to Evaluate Proprietary Cannabis Products
09/26/2018 GN Emerald Health Therapeutics Secures Long-term Supply of Hemp for CBD Extraction
09/10/2018 GN Emerald Health Therapeutics Named as Cannabis Supplier by Newfoundland Labrador Liquor Corporation to Provide Adult-Use Cannabis Products
09/07/2018 GN Emerald Health Therapeutics Confirms Supply Agreement with Ontario Cannabis Retail Corporation to Supply Adult-Use Cannabis Products
09/06/2018 GN Emerald Health Therapeutics Announces Amendment from Health Canada for Pure Sunfarms' Cultivation License, Expanding Cannabis Production Area to Approximately 550,000 Square Feet in One of the Single Largest Cannabis Growing Facilities in the World
08/30/2018 GN Emerald Health Therapeutics Reports 2nd Quarter 2018 Financial Results and Provides Corporate Update
08/27/2018 GN Emerald Health Therapeutics Signs Term Sheet to Access Large-Scale Extraction, Softgel Production, and New Product Development Capabilities Through Strategic Alliance with Factors Group of Nutritional Companies
08/24/2018 GN Emerald Health Therapeutics Engages Acorn Management Partners for Investor Relations
08/23/2018 GN Emerald Health Therapeutics Announces Amendment to Pure Sunfarms' Cultivation License, Substantially Expanding Cannabis Production Area to Approximately 420,000 Square Feet
08/15/2018 GN Emerald Health Therapeutics Completes Acquisition of Licensed Dealer Northern Vine Canada
07/30/2018 GN Emerald Health Therapeutics' Cannabis Joint Venture Pure Sunfarms Receives Sales License from Health Canada for 1.1 Million Square Foot Greenhouse
07/19/2018 GN Emerald Health Therapeutics Completes Full Acquisition of Licensed Dealer Northern Vine to Advance Product Innovation
07/12/2018 GN Emerald Health Therapeutics Updates on its Differentiated Strategy and Progress
06/27/2018 GN Emerald Health Therapeutics Announces Amendment to Pure Sunfarms' Cultivation License, Substantially Expanding Cannabis Production Area to 225,000 Square Feet
06/19/2018 GN Emerald Health Therapeutics Welcomes Historic Passing of Bill C-45 to Legalize Adult-Use Cannabis in Canada
05/29/2018 GN Emerald Health Therapeutics Reports 1st Quarter 2018 Financial Results and Provides Corporate Update

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy